دورية أكاديمية
[Will anticoagulation centres become a DOAC service?]
العنوان: | [Will anticoagulation centres become a DOAC service?] |
---|---|
عنوان ترانسليتريتد: | Wordt de trombosedienst een DOAC-dienst? |
المؤلفون: | Tieleman RG; Martini Ziekenhuis Groningen en Universitair Medisch Centrum Groningen, afd. Cardiologie.; Contact: R.G. Tieleman (r.tieleman@mzh.nl). |
المصدر: | Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2018 Nov 30; Vol. 162. Date of Electronic Publication: 2018 Nov 30. |
نوع المنشور: | Journal Article |
اللغة: | Dutch; Flemish |
بيانات الدورية: | Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Electronic Cited Medium: Internet ISSN: 1876-8784 (Electronic) Linking ISSN: 00282162 NLM ISO Abbreviation: Ned Tijdschr Geneeskd Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2017?-: Amsterdam : Vereniging NTvG Original Publication: Houten : Bohn Stafleu van Loghum |
مواضيع طبية MeSH: | Ambulatory Care Facilities/*trends , Anticoagulants/*therapeutic use , Fibrinolytic Agents/*therapeutic use , Thrombolytic Therapy/*trends, Administration, Oral ; Humans ; Netherlands |
مستخلص: | In the Netherlands, a well-organized network of anticoagulation centres has been managing anticoagulation with vitamin K antagonists for the last 60-70 years. The introduction of direct oral anticoagulant (DOAC) therapy has made treatment much more straightforward and it can now be managed by a general physician or a nurse specialized in cardiovascular risk management. The involvement of the current anticoagulation centres in anticoagulation therapy will accordingly become smaller over time, as more patients will be treated with DOACs, and anticoagulation centres in their present form may no longer be needed. |
المشرفين على المادة: | 0 (Anticoagulants) 0 (Fibrinolytic Agents) |
تواريخ الأحداث: | Date Created: 20181221 Date Completed: 20190923 Latest Revision: 20190923 |
رمز التحديث: | 20240513 |
PMID: | 30570931 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1876-8784 |
---|